14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.500 $0.720 Tuesday, 23rd Apr 2024 ADXS stock ended at $0.540. This is 5.59% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 5.47% from a day low at $0.512 to a day high of $0.540.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Feb 17, 2021 $1.13 $1.57 $1.09 $1.41 51 261 940
Feb 16, 2021 $1.17 $1.17 $1.07 $1.13 10 103 054
Feb 12, 2021 $1.12 $1.13 $1.04 $1.08 8 752 611
Feb 11, 2021 $1.13 $1.22 $1.08 $1.11 14 938 331
Feb 10, 2021 $1.23 $1.25 $1.03 $1.14 17 992 774
Feb 09, 2021 $1.09 $1.18 $1.06 $1.16 20 694 626
Feb 08, 2021 $1.02 $1.05 $0.97 $1.05 18 662 913
Feb 05, 2021 $0.98 $1.12 $0.97 $1.04 36 816 245
Feb 04, 2021 $0.751 $0.95 $0.750 $0.95 36 191 909
Feb 03, 2021 $0.720 $0.770 $0.714 $0.750 10 614 602
Feb 02, 2021 $0.733 $0.739 $0.690 $0.721 7 944 314
Feb 01, 2021 $0.737 $0.740 $0.689 $0.703 7 471 388
Jan 29, 2021 $0.680 $0.730 $0.680 $0.730 8 431 449
Jan 28, 2021 $0.713 $0.737 $0.670 $0.698 9 462 578
Jan 27, 2021 $0.705 $0.774 $0.660 $0.701 14 194 297
Jan 26, 2021 $0.777 $0.82 $0.765 $0.777 15 176 172
Jan 25, 2021 $0.769 $0.85 $0.730 $0.760 16 553 793
Jan 22, 2021 $0.788 $0.80 $0.725 $0.745 11 320 403
Jan 21, 2021 $0.82 $0.88 $0.760 $0.790 30 065 384
Jan 20, 2021 $0.730 $0.730 $0.641 $0.692 15 473 920
Jan 19, 2021 $0.640 $0.760 $0.625 $0.718 32 359 467
Jan 15, 2021 $0.640 $0.645 $0.600 $0.610 7 966 410
Jan 14, 2021 $0.643 $0.665 $0.611 $0.636 10 889 813
Jan 13, 2021 $0.655 $0.724 $0.620 $0.681 21 525 756
Jan 12, 2021 $0.696 $0.740 $0.600 $0.649 27 062 558
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT